Search hospitals > Pennsylvania > Hanover
Cherry Tree Cancer Center
Claim this profileHanover, Pennsylvania 17331
Global Leader in Lung Cancer
Global Leader in Thyroid Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Relapse
101 reported clinical trials
7 medical researchers
Summary
Cherry Tree Cancer Center is a medical facility located in Hanover, Pennsylvania. This center is recognized for care of Lung Cancer, Thyroid Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Relapse and other specialties. Cherry Tree Cancer Center is involved with conducting 101 clinical trials across 159 conditions. There are 7 research doctors associated with this hospital, such as Chanh T. Huynh, Dan Sotirescu, Joseph Kannarkatt, and Eav K. Lim.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage II
Stage I
2Thyroid Cancer
Global LeaderStage III
Stage II
Stage IV
Top PIs
Chanh T. HuynhAdams Cancer Center2 years of reported clinical research
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
21 reported clinical trials
38 drugs studied
Dan SotirescuEphrata Cancer Center6 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Thyroid Cancer
11 reported clinical trials
28 drugs studied
Joseph KannarkattWellSpan Medical Oncology and Hematology4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
31 drugs studied
Eav K. LimEphrata Cancer Center8 years of reported clinical research
Studies Endometrioid Carcinoma
Studies Thyroid Cancer
4 reported clinical trials
13 drugs studied
Clinical Trials running at Cherry Tree Cancer Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Breast cancer
ALK Gene Rearrangement
Squamous Cell Carcinoma
Cancer
Thyroid Cancer
Anaplastic Large Cell Lymphoma
Lung Carcinoma
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Cherry Tree Cancer Center?
Cherry Tree Cancer Center is a medical facility located in Hanover, Pennsylvania. This center is recognized for care of Lung Cancer, Thyroid Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Relapse and other specialties. Cherry Tree Cancer Center is involved with conducting 101 clinical trials across 159 conditions. There are 7 research doctors associated with this hospital, such as Chanh T. Huynh, Dan Sotirescu, Joseph Kannarkatt, and Eav K. Lim.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.